Zhongnan Medical Journal Press

Home Results

A total of 5 result was found. Results that relate to LIU Min

A case of severe immune liver injury caused by pembrolizumab and rechallenge

Published on Chinese Journal of Pharmacoepidemiology 2024,33(2):212-217.
6915 times 1704 times

LIU Min YANG Limei YIN Yue ZHAO Bingqing

Pembrolizumab Immune related liver injury Rechallenge of immunotherapy
Details
Determination of related substances in gluaric anhydride by HPLC

Published on Frontiers in Pharmaceutical Sciences 2024,27(3):382-387.
8163 times 1631 times

LIU Min LIAN Zhenxia LIU Yanxin WANG Fan LI Xia YANG Haixia

Glutaric anhydride Succinic acid Adipic acid Related substances High performance liquid chromatography
Details
Progress of real-world research of the generic and innovator drugs under the national centralized drug procurement policy

Published on Chinese Journal of Pharmacoepidemiology 2025,34(6):690-701.
8525 times 1091 times

ZHANG Bin LIU Minna LI Xiaolin LI Jinhu LIU Tianlong

National centralized drug procurement Real world study Clinical evaluation Generic drugs Innovator drugs Effectiveness Safety
Details
Prediction of the mechanism of Wuyao decoction lyophilized powder in treating primary dysmenorrhea based on fingerprint and network pharmacology

Published on Frontiers in Pharmaceutical Sciences 2025,29(6):912-923.
6244 times 710 times

CHENG Hao HAN Danrui CHU Suxia LIU Mingsong MA Donglai DUAN Xuhong

Wuyao decoction Lyophilized powder Primary dysmenorrhea Ultra performance liquid chromatography Fingerprint Network pharmacology Mechanism of action
Details
Guide on Methodological Standards in Pharmacoepidemiology (2nd edition) and their series interpretation (10): an overview and case study of quality assessment tools

Published on Chinese Journal of Pharmacoepidemiology 2025,34(10):1113-1126.
1831 times 305 times

ZHENG Qingyong XU Caihua ZHOU Yongjia TANG Xiao ZHANG Mengjun QI Jinzhi LIU Ming GAO Ya SUN Feng TIAN Jinhui

Pharmacoepidemiology Methodology Guildelines Quality assessment tools Risk of bias
Details